Norges Bank Arrowhead Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $34.7 Million - $44.8 Million	1,585,320 New	1,585,320 $41.2 Million
Q4 2023 Feb 09, 2024	BUY	$21.2 - $31.03 $28 Million - $41 Million	1,321,927 New	1,321,927 $40.5 Million
Q3 2023 Nov 13, 2024	BUY	$26.2 - $36.08 $30 Million - $41.4 Million	1,146,325 New	1,146,325 $30.8 Million
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $31.8 Million - $43.8 Million	-1,214,783 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$25.16 - $41.38 $11 Million - $18.2 Million	-438,995 Reduced 27.69%	1,146,325 $40.9 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $29.5 Million - $48.5 Million	-1,173,173 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$23.68 - $38.51 $29.8 Million - $48.4 Million	1,257,545 New	1,257,545 $31.9 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $41.6 Million - $60.2 Million	1,485,073 New	1,485,073 $60.2 Million
Q3 2022 Nov 13, 2023	BUY	$29.63 - $48.31 $36 Million - $58.7 Million	1,214,783 New	1,214,783 $40.1 Million
Q2 2022 Aug 14, 2023	BUY	$27.79 - $50.61 $32.6 Million - $59.4 Million	1,173,173 New	1,173,173 $41.3 Million
Q1 2022 May 12, 2023	SELL	$39.62 - $69.97 $21.6 Million - $38.1 Million	-544,004 Reduced 36.63%	941,069 $43.3 Million
Q1 2022 May 09, 2022	SELL	$39.62 - $69.97 $27.4 Million - $48.3 Million	-690,823 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$58.09 - $82.51 $40.1 Million - $57 Million	690,823 New	690,823 $45.8 Million
Q3 2021 Nov 14, 2022	BUY	$58.38 - $84.96 $39.5 Million - $57.4 Million	675,857 New	675,857 $42.2 Million
Q3 2021 Nov 05, 2021	SELL	$58.38 - $84.96 $40.6 Million - $59 Million	-694,960 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$62.15 - $90.32 $43.2 Million - $62.8 Million	694,960 New	694,960 $57.6 Million
Q2 2021 Aug 10, 2021	SELL	$62.15 - $90.32 $44.5 Million - $64.7 Million	-716,613 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$61.35 - $90.47 $44 Million - $64.8 Million	716,613 New	716,613 $47.5 Million
Q1 2021 May 07, 2021	SELL	$61.35 - $90.47 $52.7 Million - $77.7 Million	-858,781 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$43.82 - $85.37 $37.6 Million - $73.3 Million	858,781 New	858,781 $65.9 Million
Q4 2020 Feb 10, 2021	SELL	$43.82 - $85.37 $36.8 Million - $71.7 Million	-840,069 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$33.21 - $51.27 $27.9 Million - $43.1 Million	840,069 New	840,069 $36.2 Million
Q3 2020 Nov 10, 2020	SELL	$33.21 - $51.27 $31 Million - $47.9 Million	-933,456 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$26.12 - $43.27 $24.4 Million - $40.4 Million	933,456 New	933,456 $40.3 Million
Q2 2020 Aug 07, 2020	SELL	$26.12 - $43.27 $27.3 Million - $45.2 Million	-1,044,194 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$20.56 - $63.12 $21.5 Million - $65.9 Million	1,044,194 New	1,044,194 $30 Million
Q1 2020 May 08, 2020	SELL	$20.56 - $63.12 $21.5 Million - $65.9 Million	-1,044,194 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$28.14 - $73.01 $29.4 Million - $76.2 Million	1,044,194 New	1,044,194 $66.2 Million
Q4 2019 Feb 12, 2020	SELL	$28.14 - $73.01 $13.7 Million - $35.5 Million	-486,682 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$26.26 - $34.86 $12.8 Million - $17 Million	486,682 New	486,682 $13.7 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account